The results of SOD1 knockdown/knockout and the pharmacological SOD1 inhibition using ATN-224 demonstrated a significant influence of SOD1 on the adaptation of glioma cells to the tumor microenvironment. The gene discussed is SOD1; the disease is central nervous system cancer.